# EDGAR Filing Document

**Accession Number:** 0001246224
**File Stem:** 0001225208-23-002445
**Filing Date:** 2023-2
**Character Count:** 7166
**Document Hash:** e3a1ec5838832052d7be842c4d892170
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001225208-23-002445.hdr.sgml**: 20230221

**ACCESSION NUMBER**: 0001225208-23-002445

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230216

**FILED AS OF DATE**: 20230221

**DATE AS OF CHANGE**: 20230221

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** ALEXOS NICHOLAS W
- **CENTRAL INDEX KEY:** 0001246224

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37443
- **FILM NUMBER:** 23649977

**MAIL ADDRESS:**
- **STREET 1:** C/O DENTSPLY SIRONA INC
- **STREET 2:** 13320 BALLANTYNE CORPORATE PLACE
- **CITY:** CHARLOTTE
- **STATE:** NC
- **ZIP:** 28277
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Univar Solutions Inc.
- **CENTRAL INDEX KEY:** 0001494319
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-CHEMICALS & ALLIED PRODUCTS [5160]
- **IRS NUMBER:** 261251958
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 3075 HIGHLAND PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 331-777-6000

**MAIL ADDRESS:**
- **STREET 1:** 3075 HIGHLAND PARKWAY
- **STREET 2:** SUITE 200
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Univar Inc.
- **DATE OF NAME CHANGE:** 20100615

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>ALEXOS NICHOLAS W<br><sub>(Last) (First) (Middle)</sub><br>C/O UNIVAR SOLUTIONS INC.<br>3075 HIGHLAND PARKWAY, SUITE 200<br><sub>(Street)</sub><br>DOWNERS GROVE, IL 60515<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-16 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_EVP, CFO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Univar Solutions Inc. [ UNVR ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Performance-Based Restricted Stock Units | <sup>(1)</sup> | 2023-02-16 |  | A |  | 15718 |  | <sup>(2)</sup> | <sup>(2)</sup> | Common Stock | 15718 | 0<sup>(1)</sup> | 23577 | D |  |
| Restricted Stock Units - 23 | <sup>(3)</sup> | 2023-02-17 |  | A |  | 26030 |  | <sup>(4)</sup> | <sup>(4)</sup> | Common Stock | 26030 | 0<sup>(3)</sup> | 26030 | D |  |

---

### Footnotes:

(1) Each performance restricted stock unit ("PRSU") represents a contingent right to receive, at settlement, one share of common stock upon vesting.

(2) In 2021, the Reporting Person was granted an award of PRSUs ("2021 PRSUs"). The second tranche of 2021 PRSUs ("Tranche 2 2021 PRSUs") was to be earned based on a predetermined Adjusted Earnings Per Share performance goal during the period January 1, 2022 to December 31, 2022 ("Performance Goal") followed by continued employment through December 31, 2023. The reported number of securities represents the Tranche 2 2021 PRSUs that were deemed conditionally earned on February 16, 2023 following the certification of the attainment of the Performance Goal by the Compensation Committee, and vest on December 31, 2023, subject to continued employment through such date.

(3) Each restricted stock unit is equivalent to one share of common stock upon vesting.

(4) On February 17, 2023, the reporting person was granted 26,030 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date, subject to the reporting person continuing to be employed by the issuer through each such date.

**Signature:** /s/ Noelle J. Perkins as Attorney-in-Fact for Nicholas W. Alexos  
**Date:** 2023-02-20

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**